Status:
UNKNOWN
Bio-ADM as a Biomarker of Refilling in Chronic Hemodialysis Patient
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Chronic Kidney Disease 5D
Eligibility:
All Genders
18+ years
Brief Summary
Aim of this study is to evaluate in a population of chronic kidney disease patients on dialysis (Stage 5D) the predictive value of bio-adrenomedullin (bio-ADM) level on vascular refilling rate.
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Chronic Kidney Disease patient on dialysis (stage 5D) for more than 1 month
- Anuric patient
- Exclusion criteria:
- Patient protected by law
- Patient under guardianship ou curatorship
- Patient deprived of liberty
Exclusion
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05339009
Start Date
April 1 2022
End Date
May 1 2023
Last Update
April 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UH Montpellier
Montpellier, France